Solvay Pharmaceuticals, Inc. Starts Buyback, Still Looking at Acquisitions; Shares will be Held, Not Cancelled

Bookmark and Share

Reuters -- Belgian chemicals firm Solvay surprised investors with a 356 million euro share buyback but said it still plans to use a 1.7 billion euro ($2.3 billion) gain from the sale of its drugs unit to finance acquisitions.

Back to news